Kangstem Biotech Co (XKRX:217730) Other Long Term Assets : ₩6,961 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Other Long Term Assets?

Kangstem Biotech Co's other long-term assets for the quarter that ended in Mar. 2025 was ₩6,961 Mil.

Kangstem Biotech Co's quarterly other long-term assets declined from Sep. 2024 (₩8,932 Mil) to Dec. 2024 (₩7,183 Mil) but then stayed the same from Dec. 2024 (₩7,183 Mil) to Mar. 2025 (₩6,961 Mil).

Kangstem Biotech Co's annual other long-term assets increased from Dec. 2022 (₩2,380 Mil) to Dec. 2023 (₩3,875 Mil) and increased from Dec. 2023 (₩3,875 Mil) to Dec. 2024 (₩7,183 Mil).

Kangstem Biotech Co Other Long Term Assets Historical Data

The historical data trend for Kangstem Biotech Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Other Long Term Assets Chart

Kangstem Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

1,838.97

2,675.43

2,379.66

3,875.38

7,182.79

Kangstem Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															4,131.98	9,268.18	8,932.16	7,182.79	6,961.22

Kangstem Biotech Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Kangstem Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR

Website

http://www.kangstem.com

Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines